Skip to content
OpenCapital
Get started

Abeona Therapeutics Inc. ABEO Q3 2025 earnings

Reported November 12, 2025 · Before market open

Diluted EPS-$0.10Beat by $0.17
Revenue estimate$5.6M
EPS estimate-$0.27

Next report

Aug 13, 2026 (in a month)
Revenue estimate$12.2M
EPS estimate-$0.23

Versus estimates

Revenue

Q1 2026$8.7MBeat by $4.1MQ4 2025$5.4MBeat by $975.5KQ2 2025$400.0KMiss by $6.1M

Diluted EPS

Q1 2026-$0.30Beat by $0.03Q4 2025-$0.34Beat by $0.01
Q3 2025-$0.10Beat by $0.17
Q2 2025$1.71Beat by $2.10Q1 2025-$0.24Beat by $0.11Q4 2024-$0.24Beat by $0.19

Ask the moment Abeona Therapeutics Inc. reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did Abeona Therapeutics Inc. report Q3 2025 earnings?
Abeona Therapeutics Inc. (ABEO) reported Q3 2025 earnings on November 12, 2025 before market open.
What were Abeona Therapeutics Inc.'s Q3 2025 revenue and EPS?
Abeona Therapeutics Inc. reported diluted EPS of $-0.10 for Q3 2025.
Did Abeona Therapeutics Inc. beat estimates in Q3 2025?
EPS beat the consensus estimate of $-0.27 by $0.17.
How did Abeona Therapeutics Inc.'s Q3 2025 results compare year-over-year?
Compared to the same quarter a year prior, diluted EPS grew 67.7% from $-0.31.
Where can I find Abeona Therapeutics Inc.'s Q3 2025 SEC filings?
You can read the 8-K earnings release (0001493152-25-021721) and the 10-Q periodic report (0001493152-25-021723) directly on SEC EDGAR. The filing index links above go to sec.gov.